Study to Compare Oral PF-06651600 PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

  • STATUS
    Not Recruiting
  • participants needed
    318
  • sponsor
    Pfizer
Updated on 16 June 2021
Investigator
Pfizer CT.gov Call Center
Primary Contact
Brigham and Women's Hospital (1.7 mi away) Contact
+300 other location

Summary

The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Details
Condition Ulcerative Colitis, Ulcerative Colitis (Pediatric)
Treatment PF-06651600 or Placebo, PF-06700841 or Placebo, PF-06700841, PF-06651600
Clinical Study IdentifierNCT02958865
SponsorPfizer
Last Modified on16 June 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note